Annual CFI
-$154.10 K
-$106.50 K-223.74%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual cash flow from investing activities is currently -$154.10 thousand, with the most recent change of -$106.50 thousand (-223.74%) on 31 December 2022. During the last 3 years, it has risen by +$291.20 thousand (+65.39%).ZYNE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$8400.00
+$81.20 K+90.63%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly cash flow from investing activities is currently -$8400.00, with the most recent change of +$81.20 thousand (+90.63%) on 30 June 2023.ZYNE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$200.50 K
-$8400.00-4.37%
30 June 2023
Summary:
Zynerba Pharmaceuticals TTM cash flow from investing activities is currently -$200.50 thousand, with the most recent change of -$8400.00 (-4.37%) on 30 June 2023.ZYNE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +65.4% | -100.0% | -82.8% |
| 5 y5 years | +46.3% | +85.1% | +4.6% |
ZYNE Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +5607.4% | <-9999.0% | <-9999.0% |
Zynerba Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$8400.00(-90.6%) | -$200.50 K(+4.4%) |
| Mar 2023 | - | -$89.60 K(+1110.8%) | -$192.10 K(+24.7%) |
| Dec 2022 | -$154.10 K(+223.7%) | -$7400.00(-92.2%) | -$154.10 K(+5.0%) |
| Sept 2022 | - | -$95.10 K(<-9900.0%) | -$146.70 K(+184.3%) |
| June 2022 | - | $0.00(-100.0%) | -$51.60 K(-48.0%) |
| Mar 2022 | - | -$51.60 K(<-9900.0%) | -$99.20 K(+108.4%) |
| Dec 2021 | -$47.60 K(-89.3%) | $0.00(0.0%) | -$47.60 K(-56.6%) |
| Sept 2021 | - | $0.00(-100.0%) | -$109.70 K(-17.0%) |
| June 2021 | - | -$47.60 K(<-9900.0%) | -$132.10 K(-57.0%) |
| Mar 2021 | - | $0.00(-100.0%) | -$307.10 K(-31.0%) |
| Dec 2020 | -$445.30 K(+244.1%) | -$62.10 K(+177.2%) | -$445.30 K(+3.2%) |
| Sept 2020 | - | -$22.40 K(-89.9%) | -$431.50 K(-7.3%) |
| June 2020 | - | -$222.60 K(+61.1%) | -$465.50 K(+91.6%) |
| Mar 2020 | - | -$138.20 K(+186.1%) | -$242.90 K(+87.9%) |
| Dec 2019 | -$129.40 K(-54.9%) | -$48.30 K(-14.4%) | -$129.30 K(-38.5%) |
| Sept 2019 | - | -$56.40 K(<-9900.0%) | -$210.20 K(+8.6%) |
| June 2019 | - | $0.00(-100.0%) | -$193.60 K(-34.1%) |
| Mar 2019 | - | -$24.60 K(-81.0%) | -$293.80 K(+2.5%) |
| Dec 2018 | -$286.70 K | -$129.20 K(+224.6%) | -$286.60 K(+57.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$39.80 K(-60.3%) | -$181.70 K(+17.4%) |
| June 2018 | - | -$100.20 K(+475.9%) | -$154.80 K(+141.1%) |
| Mar 2018 | - | -$17.40 K(-28.4%) | -$64.20 K(-44.4%) |
| Dec 2017 | -$115.40 K(+5.3%) | -$24.30 K(+88.4%) | -$115.40 K(+1.2%) |
| Sept 2017 | - | -$12.90 K(+34.4%) | -$114.00 K(-28.4%) |
| June 2017 | - | -$9600.00(-86.0%) | -$159.30 K(+6.4%) |
| Mar 2017 | - | -$68.60 K(+199.6%) | -$149.70 K(+36.6%) |
| Dec 2016 | -$109.60 K(-49.3%) | -$22.90 K(-60.7%) | -$109.60 K(-13.6%) |
| Sept 2016 | - | -$58.20 K(<-9900.0%) | -$126.90 K(-36.1%) |
| June 2016 | - | $0.00(-100.0%) | -$198.50 K(-16.8%) |
| Mar 2016 | - | -$28.50 K(-29.1%) | -$238.50 K(+10.3%) |
| Dec 2015 | -$216.30 K(+998.0%) | -$40.20 K(-69.0%) | -$216.30 K(+19.9%) |
| Sept 2015 | - | -$129.80 K(+224.5%) | -$180.40 K(+196.2%) |
| June 2015 | - | -$40.00 K(+534.9%) | -$60.90 K(+134.2%) |
| Mar 2015 | - | -$6300.00(+46.5%) | -$26.00 K(+32.0%) |
| Dec 2014 | -$19.70 K(+629.6%) | -$4300.00(-58.3%) | -$19.70 K(+27.9%) |
| Sept 2014 | - | -$10.30 K(+102.0%) | -$15.40 K(+202.0%) |
| June 2014 | - | -$5100.00(<-9900.0%) | -$5100.00(<-9900.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | -$2700.00 | - | - |
FAQ
- What is Zynerba Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ZYNE is -$154.10 K
What is the all time high annual CFI for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual cash flow from investing activities is -$2700.00
What is Zynerba Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ZYNE is -$8400.00
What is the all time high quarterly CFI for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly cash flow from investing activities is $0.00
What is Zynerba Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ZYNE is -$200.50 K
What is the all time high TTM CFI for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high TTM cash flow from investing activities is $0.00